DE:G51 Stock Latest News
Company AnnouncementsGenScript Biotech Reports Death of Company Secretary17h ago
Company AnnouncementsLegend Biotech Posts US$710 Million Quarterly Sales for CARVYKTI2w ago
Company AnnouncementsGenscript Biotech Halves Trading Lot Size to Boost Liquidity on Hong Kong Market1M ago
Company AnnouncementsGenscript Biotech Joins Lilly’s AI Drug Discovery Platform Amid Share Price Surge1M ago
Company AnnouncementsGenscript Biotech Reshapes Board Committees After Director’s Passing1M ago
Company AnnouncementsGenscript Biotech Details Board and Committee Structure in Governance Update1M ago
Company AnnouncementsGenscript Biotech to Raise HK$2.33 Billion via Discounted Share Placing for AIDD Expansion1M ago
- Company AnnouncementsGenScript Biotech Updates Cayman Islands Corporate Service Provider Names1M ago
Company AnnouncementsGenscript Plans Hong Kong Spin-Off Listing for Probio Technology2M ago
Company AnnouncementsGenscript Biotech Earnings Call Signals AI‑Driven Upswing2M ago
Company AnnouncementsGenscript Biotech Clarifies Board Structure and Committee Roles2M ago
Company AnnouncementsGenscript Biotech Posts Strong Core Growth but Reports Interim Loss on Legend Impact2M ago
- Company AnnouncementsGenscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution3M ago
Company AnnouncementsGenScript Associate Legend Biotech Reports Promising In Vivo CAR-T Data in B-Cell Lymphoma4M ago- Company AnnouncementsGenscript Biotech Shareholders Approve All Resolutions at 2026 AGM5M ago
- Company AnnouncementsGenscript Biotech Grants 14.7 Million RSUs to Strengthen Long-Term Incentives5M ago
Company AnnouncementsGenscript Highlights Legend Biotech’s Early In Vivo CAR-T Data for B-Cell Lymphoma5M agoCompany AnnouncementsGenscript Highlights Legend Biotech’s New CAR-T Data in Oncology Programs5M ago
Company AnnouncementsGenScript Associate Legend Biotech to Unveil New CAR-T Data at 2026 ASCO Meeting5M ago